Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HAVCR2 | Q8TDQ0 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.57 |
| ▸ | HPGD | P15428 | 8/20 | 0.57 |
| ▸ | APOBEC3G | Q9HC16 | 6/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.57 |
| ▸ | GAA | P10253 | 5/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.51 |
| ▸ | MAPT | P10636 | 6/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | UPP1 | Q16831 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5233820 | 0.77 | HAVCR2 (0.62) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 | |
| SCHEMBL19212170 | 0.76 | HAVCR2 (0.61) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 | |
| SCHEMBL4888217 | 0.76 | ALDH1A1 (0.66) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 | |
| SCHEMBL1694465 | 0.75 | KDM4E (0.62) | HAVCR2ALDH1A1HPGDHSD17B10GAA | |
| SCHEMBL16685480 | 0.69 | HAVCR2 (0.51) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 | |
| SCHEMBL1801170 | 0.69 | — | — | |
| SCHEMBL16685611 | 0.68 | HAVCR2 (0.50) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 | |
| SCHEMBL2922142 | 0.67 | HAVCR2 (0.50) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 | |
| SCHEMBL1344362 | 0.64 | KDM4E (0.46) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 | |
| SCHEMBL1926225 | 0.64 | KDM4E (0.46) | HAVCR2ALDH1A1HPGDAPOBEC3GHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250146035-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-05-08 | — | — | US | claimed |
| US-12188069-B2 | Biocatalyst and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-01-07 | — | — | US | claimed |
| EP-3746551-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | The Regents Of The University Of Michigan (US) | 2020-12-09 | — | — | EP | claimed |
| US-20200370081-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-11-26 | — | — | US | claimed |
| CN-111699248-A | Biocatalysts and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds | 密执安大学评议会 | 2020-09-22 | — | — | CN | claimed |
| WO-2019152679-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2019-08-08 | — | — | WO | claimed |
| US-20250146035-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-05-08 | — | — | US | disclosed |
| US-12188069-B2 | Biocatalyst and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-01-07 | — | — | US | disclosed |
| CN-111699248-B | Biocatalysts and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds | 密执安大学评议会 | 2024-05-24 | — | — | CN | disclosed |
| EP-3746551-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | The Regents Of The University Of Michigan (US) | 2020-12-09 | — | — | EP | disclosed |
| US-20200370081-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-11-26 | — | — | US | disclosed |
| CN-111699248-A | Biocatalysts and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds | 密执安大学评议会 | 2020-09-22 | — | — | CN | disclosed |
| WO-2019152679-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2019-08-08 | — | — | WO | disclosed |
| US-20160137664-A1 | THIENO [2,3-b] PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2016-05-19 | — | — | US | disclosed |
| EP-3008073-A1 | THIENO[2,3-b]PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2016-04-20 | — | — | EP | disclosed |
| WO-2014199195-A1 | THIENO[2,3-b]PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2014-12-18 | — | — | WO | disclosed |
| CN-101685733-A | High-temperature thermal fuse device | THERM O DISC INC | 2010-03-31 | — | — | CN | disclosed |
| EP-0104876-B1 | HERBICIDAL CYCLOHEXANE-1,3-DIONE DERIVATIVES | ICI AUSTRALIA LIMITED (AU) | 1991-12-27 | — | — | EP | disclosed |
| US-4631081-A | Herbicidal cyclohexane-1,3-dione derivatives | ICI AUSTRALIA LIMITED (AU) | 1986-12-23 | — | — | US | disclosed |
| EP-0104876-A2 | Herbicidal cyclohexane-1,3-dione derivatives | ICI AUSTRALIA LIMITED (AU) | 1984-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250146035-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | CYP4F3, CYP2E1, CYP1A2 | HAVCR2 2990/4885ALDH1A1 395/4885HPGD 157/4885 |
| US-20160137664-A1 | THIENO [2,3-b] PYRIDINES AS MULTIDRUG RESISTANCE MODULATORS | ABCC1, ABCB1, MT-CO1 | HAVCR2 1239/4885ALDH1A1 1394/4885HPGD 590/4885 |
| US-20200370081-A1 | BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS | CYP4F3, CYP2E1, CYP1A2 | HAVCR2 2990/4885ALDH1A1 395/4885HPGD 157/4885 |
| US-12188069-B2 | Biocatalyst and methods for synthesizing mixed disulfide conjugates of thienopyridine compounds | CYP4F3, CYP2E1, CYP1A2 | HAVCR2 2990/4885ALDH1A1 395/4885HPGD 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.